SUBSCRIBE
SUBSCRIBE

Asia

PEEL Therapeutics Preps IND for Prodrug Targeting Chemoresistant Tumors
A novel prodrug to combat high-risk pediatric solid tumors is being developed by PEEL Therapeutics, Inc.
August 25, 2020
 · 
5 min read
 · 
Gail Dutton
Policy
Biopharma Update on the Novel Coronavirus: August 26
Please check out the biopharma industry coronavirus (COVID-19) stories that are trending for August 26, 2020.
August 25, 2020
 · 
4 min read
 · 
BioSpace Editorial Staff
Drug Development
Case Report: 33-Year-Old Man Caught COVID-19 Twice
The genetic sequences of the two samples were markedly different, which strengthened the theory that the patient had been infected a second time.
August 25, 2020
 · 
3 min read
 · 
Mark Terry
Takeda Sells Japanese Consumer Health Business Unit for $2.3 Billion
This morning, Osaka, Japan-based Takeda officially announced the sale of TCHC to the investment firm.
August 24, 2020
 · 
2 min read
 · 
Alex Keown
Policy
China Doses Some Essential Workers with COVID-19 Vaccine Ahead of Approval
There are several China-based companies that have vaccine candidates in Phase III.
August 24, 2020
 · 
2 min read
 · 
Alex Keown
Drug Development
Biopharma Update on the Novel Coronavirus: August 24
Please check out the biopharma industry coronavirus (COVID-19) stories that are trending for August 24, 2020.
August 24, 2020
 · 
2 min read
 · 
BioSpace Editorial Staff
Drug Development
Clinical Catch-Up: August 17-21
It was a relatively quiet week for clinical trial news. Here’s a look.
August 21, 2020
 · 
5 min read
 · 
Mark Terry
Policy
Biopharma Update on the Novel Coronavirus: August 21
Please check out the biopharma industry coronavirus (COVID-19) stories that are trending for August 21, 2020.
August 20, 2020
 · 
5 min read
 · 
BioSpace Editorial Staff
Pharm Country
Takeda Continues to Shed OTC Business Offerings with $2.3 Billion Deal
Takeda continues to divest its over-the-counter business operations and has struck a deal for its U.S. offerings with The Blackstone Group, a U.S.-based investment fund valued at $2.37 billion.
August 19, 2020
 · 
2 min read
 · 
Alex Keown
Policy
Biopharma Update on the Novel Coronavirus: August 19
Please check out the biopharma industry coronavirus (COVID-19) stories that are trending for August 19, 2020.
August 17, 2020
 · 
2 min read
 · 
BioSpace Editorial Staff
Load More
PRESS RELEASES
Press Releases
YD Bio Limited Announces Strategic Partnership with YC Biotech Co., Ltd. to Establish a Taiwan-U.S. Dual-Core Regulatory Platform
February 25, 2026
 · 
5 min read
Press Releases
George Medicines advances its global commercial strategy for GMRx2 with an exclusive licensing agreement with Orient EuroPharma in Southeast Asia
February 25, 2026
 · 
6 min read
Press Releases
HekaBio and Alpha Tau Medical Obtain Approval in Japan for Solid Tumor Treatment Alpha DaRT
February 25, 2026
 · 
7 min read
Press Releases
Antengene Announces Clinical Collaboration with Junshi Biosciences to Explore the Synergistic Potential of ATG-037 (Oral CD73 Inhibitor) In Combination with JS207 (PD-1/VEGF BsAb)
February 25, 2026
 · 
8 min read
Press Releases
Junshi Biosciences Announces Strategic Collaboration with Antengene to Evaluate Combination Therapy with JS207 (PD-1/VEGF BsAb) and ATG-037 (Oral CD73 Inhibitor)
February 25, 2026
 · 
8 min read
Press Releases
Sarepta Therapeutics Announces Commercial Launch of ELEVIDYS in Japan
February 25, 2026
 · 
12 min read
Press Releases
Respiree Strengthens Series A Syndicate to Advance Next-Generation Cardiorespiratory Care
February 24, 2026
 · 
2 min read
Press Releases
C-Ray Therapeutics Achieves AAALAC International Full Accreditation, Reinforcing Commitment to Excellence in Preclinical Research
February 24, 2026
 · 
3 min read
Press Releases
Alpha Tau Medical Receives Japanese Marketing Approval for Alpha DaRT® in Unresectable Locally Advanced or Locally Recurrent Head and Neck Cancer
February 24, 2026
 · 
7 min read
Press Releases
Transcenta Therapeutics to Present at the 36th Annual Oppenheimer Healthcare Life Sciences Conference
February 24, 2026
 · 
1 min read
Press Releases
Novo Nordisk: Triple agonist UBT251 delivers up to 19.7% mean weight loss after 24 weeks in phase 2 trial in China
February 24, 2026
 · 
5 min read
Press Releases
Sciwind Biosciences Partners with Pfizer China to Commercialize its Biased GLP-1 in China
February 24, 2026
 · 
3 min read
Press Releases
Astellas and Vir Biotechnology Announce Global Strategic Collaboration to Advance PSMA-targeting PRO-XTEN® Dual-masked T-Cell Engager VIR-5500 for the Treatment of Prostate Cancer
February 24, 2026
 · 
10 min read
Press Releases
BioNexus Gene Lab Corp. Completes Chemrex Governance Restructuring; Appoints Matthew Barsing as Chairman
February 23, 2026
 · 
6 min read
Press Releases
iRegene Hits Dual Global Firsts: U.S. Patient Dosed in Phase IIa for NouvNeu001 in Parkinson’s and First Enrollment in China’s Randomized MSA Trial for NouvNeu004
February 23, 2026
 · 
5 min read
Press Releases
Ascentage Pharma to Participate in Three Upcoming March 2026 Investor Conferences
February 23, 2026
 · 
5 min read
Press Releases
Formosa Pharmaceuticals Announces Licensing Agreement with Arrotex, for Commercialization of Clobetasol Propionate Ophthalmic Suspension for the Treatment of Inflammation and Pain Following Ocular Surgery
February 23, 2026
 · 
4 min read
Press Releases
CStone Announces MHRA Approval in UK for Sugemalimab in Stage III NSCLC
February 22, 2026
 · 
6 min read
Press Releases
ImmunityBio Partners with Biopharma and Cigalah Healthcare to Launch ANKTIVA® in Saudi Arabia for Bladder and Lung Cancer Patients
February 20, 2026
 · 
10 min read
Press Releases
Daiichi Sankyo Appoints John Tsai, MD as Global Head of R&D
February 19, 2026
 · 
2 min read
Load More